A detailed history of Ami Asset Management Corp transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Ami Asset Management Corp holds 10,964 shares of BPMC stock, worth $961,104. This represents 0.06% of its overall portfolio holdings.

Number of Shares
10,964
Holding current value
$961,104
% of portfolio
0.06%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 23, 2025

BUY
$86.69 - $115.63 $950,469 - $1.27 Million
10,964 New
10,964 $970,000

Others Institutions Holding BPMC

About Blueprint Medicines Corp


  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.24B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Ami Asset Management Corp Portfolio

Follow Ami Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ami Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Ami Asset Management Corp with notifications on news.